Wuxi Boton Technology Co., Ltd. (300031.SZ)
CNY 23.28
(0.09%)
CNY 23.28
(0.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 430.75 Million | 12.13 Million | 152.35 Million | 277.76 Million | 378.53 Million | 181.16 Million |
| Net Income | 110.99 Million | -468.63 Million | 383.38 Million | 441.01 Million | 286.42 Million | 289 Million |
| Depreciation & Amortization | 120.8 Million | 9.45 Million | 53.4 Million | 40.39 Million | 35.57 Million | 34.44 Million |
| Deferred income taxes | -33.85 Million | 4.87 Million | 16.27 Million | 19.7 Million | -987.3 Thousand | -376.45 Thousand |
| Stock-based compensation | 23.46 Million | 7.02 Million | -274.26 Thousand | 24.59 Million | - | - |
| Change in working capital | -34.72 Million | -84.48 Million | -181.62 Million | -109.97 Million | -55.75 Million | -243.28 Million |
| Other non-cash items | 67.83 Million | 543.9 Million | -118.81 Million | -137.96 Million | 112.29 Million | 100.99 Million |
| Investing Cash Flow | -819.9 Million | 228.14 Million | -324.79 Million | -624.66 Million | -135.89 Million | -52.11 Million |
| Investments in PPE | -276.15 Million | -126.98 Million | -279.1 Million | -278.75 Million | -120.39 Million | -15.39 Million |
| Acquisitions | 60.03 Million | 51.45 Million | 2.92 Million | 5015.38 | 104.49 Thousand | 60.07 Thousand |
| Investment purchases | -131.29 Million | -538.49 Million | -490.52 Million | -437.11 Million | -16.6 Million | -31.08 Million |
| Sales/Maturities of investments | 79.09 Million | 857.81 Million | 478.65 Million | 89.7 Million | 136.39 Thousand | 883.46 Thousand |
| Other Investing Activities | -492.12 Million | -15.64 Million | -36.72 Million | 1.5 Million | 872.35 Thousand | -6.57 Million |
| Financing Cash Flow | 90.29 Million | 62.84 Million | 69.93 Million | 310 Million | 13.93 Million | -406.53 Million |
| Debt repayment | -54.1 Million | -538.74 Million | -458.33 Million | -1.07 Billion | -2.2 Billion | -45 Million |
| Dividends payments | -24.19 Million | -41.19 Million | -115.53 Million | -120.1 Million | -22.35 Million | -59.53 Million |
| Common Stock Repurchased | - | - | - | - | - | -152.03 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 61.68 Million | 671.56 Million | 681.1 Million | 1.5 Billion | 2.24 Billion | -302 Million |
| Accounts receivables | -173.61 Million | -1.03 Billion | -276.57 Million | -210.34 Million | -204.1 Million | -207.21 Million |
| Accounts payables | 134.99 Million | 998.9 Million | 96.3 Million | 109.74 Million | 171.28 Million | 20.56 Million |
| Inventory | 37.75 Million | -50.25 Million | -17.64 Million | -29.07 Million | -21.94 Million | -56.25 Million |
| Other working capital | 23.46 Million | 4.87 Million | 16.27 Million | 19.7 Million | -987.3 Thousand | -187.02 Million |
| Cash at beginning of period | 786.01 Million | 455.41 Million | 567.44 Million | 615.72 Million | 352.1 Million | 612.66 Million |
| Cash at end of period | 503.13 Million | 786.01 Million | 455.41 Million | 567.44 Million | 615.72 Million | 352.1 Million |
| Capital Expenditure | -276.15 Million | -126.98 Million | -279.1 Million | -278.75 Million | -120.39 Million | -15.39 Million |
| Effect of forex changes on cash | 15.97 Million | 27.48 Million | -9.52 Million | -11.38 Million | 7.03 Million | 16.92 Million |
| Net cash flow / Change in cash | -282.87 Million | 330.59 Million | -112.02 Million | -48.27 Million | 263.61 Million | -260.55 Million |
| Free Cash Flow | 154.59 Million | -114.85 Million | -126.74 Million | -991.1 Thousand | 258.14 Million | 165.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.97 Million | 104.85 Million | 85.86 Million | 110.99 Million | 2.64 Million | -18.48 Million |
| Depreciation & Amortization | - | 43.27 Million | 43.27 Million | 120.8 Million | 45.79 Million | -49.17 Million |
| Deferred income taxes | - | - | - | -33.85 Million | - | 1.52 Billion |
| Stock-based compensation | - | 8.84 Million | - | 23.46 Million | 23.46 Million | -9.43 Million |
| Change in working capital | - | 156.47 Million | - | -34.72 Million | -112.39 Million | -1.46 Billion |
| Other non-cash items | 88.51 Million | -70.76 Million | 75.75 Million | 67.83 Million | 373.16 Million | 14.86 Million |
| Investing Cash Flow | -537.18 Million | 46.37 Million | 1.87 Million | -819.9 Million | -662.76 Million | -56.1 Million |
| Investments in PPE | -168.69 Million | -86.28 Million | -111.16 Million | -276.15 Million | -170.26 Million | -11.43 Million |
| Acquisitions | 31.95 Million | 1.51 Million | -48.34 Thousand | 60.03 Million | 355.34 Thousand | 551.42 Thousand |
| Investment purchases | - | - | - | -131.29 Million | 13.38 Million | -44.76 Million |
| Sales/Maturities of investments | 14.1 Million | - | 1.49 Million | 79.09 Million | -1.21 Million | 87.01 Thousand |
| Other Investing Activities | -368.48 Million | 131.15 Million | 111.59 Million | -492.12 Million | -504.66 Million | -547.96 Thousand |
| Financing Cash Flow | 30.63 Million | -70.42 Million | 134.94 Million | 90.29 Million | -22.28 Million | 80.8 Million |
| Debt repayment | -10.33 Million | -41.86 Million | -129.6 Million | -54.1 Million | -9.3 Million | -90 Million |
| Dividends payments | -1.6 Million | -30.92 Million | -4.3 Million | -24.19 Million | -6.71 Million | -4.83 Million |
| Common Stock Repurchased | - | - | - | - | -26.9 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 21.9 Million | -10.5 Million | 9.64 Million | 61.68 Million | -4.97 Million | 175.64 Million |
| Accounts receivables | - | 153.27 Million | - | -173.61 Million | -173.61 Million | -1.49 Billion |
| Accounts payables | - | - | - | 134.99 Million | - | 409.82 Thousand |
| Inventory | - | -4.83 Million | - | 37.75 Million | 37.75 Million | 26.74 Million |
| Other working capital | - | 8.03 Million | - | 23.46 Million | 23.46 Million | -409.82 Thousand |
| Cash at beginning of period | 763.17 Million | 1.33 Billion | 503.13 Million | 786.01 Million | 859.76 Million | 841.28 Million |
| Cash at end of period | 426.9 Million | 1.18 Billion | 797.19 Million | 503.13 Million | 503.13 Million | 859.76 Million |
| Capital Expenditure | -168.69 Million | -86.28 Million | -111.16 Million | -276.15 Million | -170.26 Million | -11.43 Million |
| Effect of forex changes on cash | 37.62 Million | -803.32 Thousand | -2.88 Million | 15.97 Million | 806.12 Thousand | -2.59 Million |
| Net cash flow / Change in cash | -336.27 Million | -151.86 Million | 294.05 Million | -282.87 Million | -356.62 Million | 18.48 Million |
| Free Cash Flow | -33.21 Million | -95.46 Million | 50.44 Million | 154.59 Million | 159.74 Million | -15.05 Million |
301190
SGRO
300684
0SAY
KOHINOOR
KLINIQ